Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer
Recruiting now · Not applicable
Conditions studied: Gastroesophageal Junction Cancer, Stomach Neoplasms, Esophageal Neoplasms
In brief
This multicenter prospective randomized clinical trial aims to compare the safety and oncological effectiveness of proximal gastrectomy and total gastrectomy in patients with locally advanced Siewert type II-III gastroesophageal junction cancer. Eligible patients will be randomly assigned to undergo either proximal gastrectomy or total gastrectomy using open, laparoscopic, or robotic surgical approaches according to clinical suitability. The primary outcome of the study is 3-year disease-free survival. Secondary outcomes include postoperative mortality, postoperative complications, and the number of metastatic lymph nodes retrieved. Patients will be followed for up to five years after surgery to evaluate long-term oncological outcomes.
Key facts
- Study ID
- NCT07482566
- Run by
- Nurettin Şahin
- People needed
- 120
- Starts
- 2026-02-01
- Expected to finish
- 2033-02-01
- Last updated by the study team
- 2026-03-20
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age between 18 and 90 years
- Histologically confirmed locally advanced Siewert type II-III gastroesophageal junction cancer
- Considered operable after multidisciplinary tumor board evaluation
- Candidate for curative surgical resection with D2 lymphadenectomy
- Provision of written informed consent
You may not qualify if…
- Early-stage gastroesophageal junction cancer
- Gastric cancers located in the antrum or corpus
- Severe anesthetic risk (American Society of Anesthesiologists [ASA] class IV or higher)
- Pregnancy
- Patients unwilling or unable to provide informed consent
Where it is running
- Bakirkoy Dr. Sadi Konuk Training and Research Hospital — Istanbul, Istanbul, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.